WealthShield Partners’s Gilead Sciences GILD Stock Holding History

WealthShield Partners’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.94M	Sell	13,932 -168	-1%	-$23.5K	0.22%	129
2025 Q4	$1.73M	Buy	+14,100	New	+$1.71M	0.19%	129
2021 Q3	–	Sell	-2,437	Closed	-$168K	–	435
2021 Q2	$168K	Buy	2,437 +739	+44%	+$49.3K	0.03%	286
2021 Q1	$110K	Buy	+1,698	New	+$109K	0.02%	326
2018 Q2	–	Sell	-2,739	Closed	-$206K	–	253
2018 Q1	$206K	Buy	+2,739	New	+$218K	0.13%	116

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

WealthShield Partners's GILD Position: Q1 2026 in Review

WealthShield Partners reduced its Gilead Sciences (GILD) stake by 1.2% in Q1 2026, selling an estimated $23.5K and leaving 13,932 shares worth $1.94M. The position accounts for 0.22% of the portfolio, ranked #129.

WealthShield Partners first reported a position in GILD in Q1 2018 and has held it in 5 quarters since. 2,310 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

WealthShield Partners held 13,932 shares of Gilead Sciences worth $1.94M as of Q1 2026.
WealthShield Partners sold 168 Gilead Sciences shares in Q1 2026, an estimated $23.5K.
Gilead Sciences made up 0.22% of WealthShield Partners's portfolio in Q1 2026, its #129 holding.
WealthShield Partners first reported a position in Gilead Sciences in Q1 2018 and has held it in 5 quarters since.
2,310 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on WealthShield Partners's 13F filing for Q1 2026, filed 1 May 2026.